Paul M. Ridker

Institution information unavailable

Research Areas

Discover Papers by Paul M. Ridker

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

227

Publications

1382

Citations

235725

i10-index

892

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Antiinflammatory Therapy with Canakinumab for Athe...	2017	9416
Inflammation and Atherosclerosis	2002	7719
Rosuvastatin to Prevent Vascular Events in Men and...	2008	6699
Inflammation, Aspirin, and the Risk of Cardiovascu...	1997	5534
Progress and challenges in translating the biology...	2011	4005
Rosuvastatin to Prevent Vascular Events in Men and...	2009	3646
Comparison of C-Reactive Protein and Low-Density L...	2002	3620
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANT...	1994	3325
From Vulnerable Plaque to Vulnerable Patient	2003	2668
Clinical Application of C-Reactive Protein for Car...	2003	2522

Publications

1.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Year: 2017Citations: 9416DOI: 10.1056/nejmoa1707914
2.
Inflammation and Atherosclerosis
Year: 2002Citations: 7719DOI: 10.1161/hc0902.104353
3.
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Year: 2008Citations: 6699DOI: 10.1056/nejmoa0807646
4.
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
Year: 1997Citations: 5534DOI: 10.1056/nejm199704033361401
5.
Progress and challenges in translating the biology of atherosclerosis
Year: 2011Citations: 4005DOI: 10.1038/nature10146
6.
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Year: 2009Citations: 3646DOI: 10.1097/01.ogx.0000344393.60303.0a
7.
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
Year: 2002Citations: 3620DOI: 10.1056/nejmoa021993
8.
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Year: 1994Citations: 3325
9.
From Vulnerable Plaque to Vulnerable Patient
Year: 2003Citations: 2668DOI: 10.1161/01.cir.0000087481.55887.c9
10.
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
Year: 2003Citations: 2522DOI: 10.1161/01.cir.0000053730.47739.3c

About Paul M. Ridker

Paul M. Ridker is a researcher with 1382 publications and 235725 citations. Their research focuses on . With an h-index of 227, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Paul M. Ridker and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year